Literature DB >> 22258514

Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease.

Yao-Yao Xing1, Jin-Tai Yu, Wei-Zhen Cui, Xiao-Ling Zhong, Zhong-Chen Wu, Qun Zhang, Lan Tan.   

Abstract

Variants in the clusterin gene have been associated with Alzheimer's disease (AD) through replicated genome-wide studies, but the underlying mechanisms remain unknown. In this study the association of the AD clusterin common risk polymorphism rs9331888 with blood clusterin levels was tested in 104 AD subjects and 104 healthy controls. Blood clusterin levels were significantly elevated in AD patients (p < 0.05). The rs9331888 AD-risk variant was associated with low clusterin mRNA and protein levels in an allele-dose dependent manner in both groups (p < 0.001). This study indicates that the rs9331888 AD-risk variant is associated with low blood clusterin levels.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22258514     DOI: 10.3233/JAD-2011-111844

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  19 in total

Review 1.  HDL-cholesterol and apolipoproteins in relation to dementia.

Authors:  Manja Koch; Majken K Jensen
Journal:  Curr Opin Lipidol       Date:  2016-02       Impact factor: 4.776

Review 2.  The role of clusterin in Alzheimer's disease: pathways, pathogenesis, and therapy.

Authors:  Jin-Tai Yu; Lan Tan
Journal:  Mol Neurobiol       Date:  2012-01-25       Impact factor: 5.590

3.  CLU rs9331888 Polymorphism Contributes to Alzheimer's Disease Susceptibility in Caucasian But Not East Asian Populations.

Authors:  Shuyan Zhang; Xuling Li; Guoda Ma; Yongshuai Jiang; Mingzhi Liao; Rennan Feng; Liangcai Zhang; Jiafeng Liu; Guangyu Wang; Bin Zhao; Qinghua Jiang; Keshen Li; Guiyou Liu
Journal:  Mol Neurobiol       Date:  2015-01-30       Impact factor: 5.590

Review 4.  Correlation of rs9331888 polymorphism with Alzheimer's disease among Caucasian and Chinese populations: a meta-analysis and systematic review.

Authors:  Bin Zhu; Rui Min Wang; Jian Ting Wang; Rui Ling Chen; Yan Fei Zheng; Lei Zhang; Zhi Gang Zhao
Journal:  Metab Brain Dis       Date:  2017-02-06       Impact factor: 3.584

Review 5.  [Search for risk genes in Alzheimer's disease].

Authors:  I Karaca; H Wagner; A Ramirez
Journal:  Nervenarzt       Date:  2017-07       Impact factor: 1.214

Review 6.  Alzheimer's disease genetics: from the bench to the clinic.

Authors:  Celeste M Karch; Carlos Cruchaga; Alison M Goate
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

7.  Association between clusterin concentration and dementia: a systematic review and meta-analysis.

Authors:  Caiping Yang; Hai Wang; Chaojiu Li; Huiyan Niu; Shunkui Luo; Xingzhi Guo
Journal:  Metab Brain Dis       Date:  2018-10-05       Impact factor: 3.584

8.  Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci.

Authors:  Patrick Holton; Mina Ryten; Michael Nalls; Daniah Trabzuni; Michael E Weale; Dena Hernandez; Helen Crehan; J Raphael Gibbs; Richard Mayeux; Jonathan L Haines; Lindsay A Farrer; Margaret A Pericak-Vance; Gerard D Schellenberg; Manuel Ramirez-Restrepo; Anzhelika Engel; Amanda J Myers; Jason J Corneveaux; Matthew J Huentelman; Allissa Dillman; Mark R Cookson; Eric M Reiman; Andrew Singleton; John Hardy; Rita Guerreiro
Journal:  Ann Hum Genet       Date:  2013-01-30       Impact factor: 1.670

Review 9.  Alzheimer's disease risk genes and mechanisms of disease pathogenesis.

Authors:  Celeste M Karch; Alison M Goate
Journal:  Biol Psychiatry       Date:  2014-05-17       Impact factor: 13.382

Review 10.  The complotype: dictating risk for inflammation and infection.

Authors:  Claire L Harris; Meike Heurich; Santiago Rodriguez de Cordoba; B Paul Morgan
Journal:  Trends Immunol       Date:  2012-06-29       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.